Our Commitment

Transforming lives is our only standard of success and is at the heart of everything we do

Patients first. It’s the core value that drives every decision we make, from which therapies to pursue, to how we will pursue them. Our focus is fixed on providing the effective treatments that are so desperately needed for disorders of the central nervous system (CNS). So, we measure success by answering one question: Does this medicine produce a profound, life-transforming effect on the lives of people with CNS disorders? We won’t rest until the answer is “yes.”

Infant’s hand gripped around an adult’s finger

Woman with her arm around another woman, comforting her

Building Support

At Passage Bio, we believe that collaboration is an important component of transformation, and we are committed to working with patient advocacy groups that are also committed to transforming lives.

We would like to connect with patients and caregivers through patient advocacy groups to learn more about their journeys and how we can assist them. Share your thoughts and ideas through email. Your input will help us develop new support and educational resources that can empower patients and caregivers in their journey.

Key collaborations

We remain focused, through a variety of initiatives, on identifying patients as early as possible who may benefit from our investigational therapies.

Informed DNA, a partnership that involves designing and supporting a genetic screening and counseling program that will be free of charge to people with frontotemporal disease.

Learn more at informeddna.com.

Invitae, a leading medical genetics company that facilitates genetic testing and supports early identification of children with GM1 gangliosidosis.

Learn more at invitae.com.